Related Experiment Videos

[Hematologic aspects of inflammatory bowel diseases]

M Udvardy1, I Altorjay, K Palatka

  • 1Debreceni Egyetem, Orvos- és Egészségtudományi Centrum, II. Belgyógyászati Klinika.

Orvosi Hetilap
|May 26, 2001
PubMed

Anaemia, thrombocytosis are common secondary changes in inflammatory bowel disease (IBD), reflecting the clinical severity of the IBD cases, too. On the other hand, increased platelet function, fibrinolytic abnormalities, hypercoagulation of IBD patients predispose to thromboembolic events, and they may as well contribute to the local microcirculatory alterations leading to IBD itself. Reduced FXIII levels have been observed in IBD, which seems to be correlated with mucosal repair and might have therapeutic importance, too. Genetic thrombophilia received much attention recently, however, much less is known how frequent they are in IBD, what their clinical significance is, do they modify the clinical course itself. A short, concise review about links between haematology and IBD is given.

Related Concept Videos